Clinical Trial Update: A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating HDM2005 in combination with standard of care for diffuse large B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• HDM2005

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Diffuse Large B Cell Lymphoma (DLBCL) | Phase 1, Phase 2 | Status: RECRUITING